Subscriptions

EpicOncology™ Platform Subscription Options

We quote EpicOncology™ subscriptions according to your R&D needs. Whether it’s a subscription for the full package—all cancers, all countries, all analyses—or a more limited data set, such as one country’s worth of data, or selected cancers.

Your goals determine the type and amount of data to which you subscribe. We determine pricing by listening to those goals, and calibrating your EpicOncology™ subscription to match.

How We Calibrate Your EpicOncology™ Subscription

We work together to weigh factors like:

  • Which countries are you interested in (e.g. G8, Western Europe, USA, Japan, China, etc.)?
  • Which cancers do you need?
  • Do you need any particular patient subtypes?
  • Are you a new or existing Epiphany customer?

What about EpicOncology‘s central features? Which do you get access to with a partial subscription?

All of them! Even a partial subscription still gives you access to what you need from each of the EpicOncology™ Features…either the entire feature, or a relevant component to your data queries.

Here’s a breakdown of data set access for each feature included with partial subscriptions:

  • Epic AnalysesYou can collect & query data sets from all the country(s) / cancer(s) in your subscription.
  • Epic Flow DiagramsAccess to all flow diagrams for the country(s) / cancer(s) in your subscription.
  • Physician SurveysAccess to oncology surveys for the G7 country(s) / cancer(s) in your subscription.
  • InsightsCustom query builder included; populated by the country(s) / cancer(s) in your subscription.

Regardless of your subscription calibration, you will always have full access to information provided in our References section (e.g., analysis definitions, and disease-specific definitions for ALL cancers covered in EpicOncology™).

Let's go through an example.

Heavenly Genetics is a small, but growing biopharma firm with one product launched in the USA market. This product helps doctors treat early-stage esophageal cancer. It shows an excellent success rate so far.

They want to develop a new product, focused on the same type of treatment results for early-stage squamous cell non-small cell lung cancer. They are still in research phase, and need epidemiology data to round out their development process & launch trials.

In such a case, we would determine that their EpicOncology™ Subscription should include:

  1. Country-specific data limited to U.S. only
  2. Detailed dataset for both esophageal and non-small cell lung cancer

Flexible Pricing to Meet Your Biopharm Insights Needs

You won’t find “subscription tiers” for EpicOncology™ that price the data you need just out of reach.

Every customer receives their own subscription, reflecting their R&D needs. We’re happy to recommend certain data sets, but the final decision is yours.

Not sure how many data sets you’ll want? Test-drive the EpicOncology™ platform!